ZYME
Zymeworks Inc. Common Stock
NASDAQ: ZYME · HEALTHCARE · BIOTECHNOLOGY
$27.83
-0.39% today
Updated 2026-04-29
Market cap
$2.07B
P/E ratio
—
P/S ratio
19.51x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$11 – $30
Volume
0.7M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F6.0
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$40.08
+44.02%
12-Month target
—
—
Intrinsic (DCF)
$32.28
Margin of safety
+29.28%
2 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 29.28% below intrinsic value
Risks
- Thin margins at -76.60%
- Negative free cash flow $-10.55M
- Revenue declining -91.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $412.48M | $76.01M | $76.30M | $105.97M | $105.97M |
| Net income | $124.34M | $-118.67M | $-122.69M | $-81.13M | $-41.21M |
| EPS | — | — | — | — | $-1.08 |
| Free cash flow | $130.98M | $-122.38M | $-113.11M | $-34.53M | $-10.55M |
| Profit margin | 30.14% | -156.13% | -160.80% | -76.56% | -76.60% |
Peer comparison
Smart narrative
Zymeworks Inc. Common Stock trades at $27.83. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $105.97M. with profit margins at -76.60%. Our DCF model estimates intrinsic value at $32.28.
Frequently asked questions
What is Zymeworks Inc. Common Stock's stock price?
Zymeworks Inc. Common Stock (ZYME) trades at $27.83.
Is Zymeworks Inc. Common Stock overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $32.28.
What is the price target of Zymeworks Inc. Common Stock (ZYME)?
The analyst target price is $40.08, representing +44.0% upside from the current price of $27.83.
What is the intrinsic value of Zymeworks Inc. Common Stock (ZYME)?
Based on our DCF model, intrinsic value is $32.28, a +29.3% margin of safety versus $27.83.
What is Zymeworks Inc. Common Stock's revenue?
TTM revenue is $105.97M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio19.51x
ROE-26.70%
Beta1.20
50D MA$25.25
200D MA$20.91
Shares out0.07B
Float0.07B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—